Adipose Tissue, Metabolic Syndrome, and Non-Alcoholic Fatty Liver Disease – A Short Review - European Medical Journal

Continue

Adipose Tissue, Metabolic Syndrome, and Non-Alcoholic Fatty Liver Disease – A Short Review

Hepatology
Download PDF
Authors:
Panayiotis Kouis, Despina Pampaka, *Andrie G Panayiotou

Cyprus International Institute for Environmental and Public Health in association with the Harvard School of Public Health, Cyprus University of Technology, Limassol, Cyprus
*Correspondence to [email protected]

Disclosure:

No potential conflict of interest.

Received:
16.12.13
Accepted:
27.02.14
Citation:
EMJ Hepatol. ;1[1]:62-70. DOI/10.33590/emjhepatol/10311666. https://doi.org/10.33590/emjhepatol/10311666.
Keywords:
NAFLD, adipose tissue, insulin resistance, metabolic syndrome, genetics of NAFLD.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease globally, and it is expected to rise even further as a result of the increase in obesity and related risk factors. This short review summarises current evidence on the role of adipose tissue and insulin resistance in NAFLD and the interrelationship between NAFLD and the metabolic syndrome (MetS), considering central adiposity is a major feature of both the MetS and NAFLD, and that NAFLD has been previously described as the hepatic manifestation of the MetS. In addition, genetic studies of NAFLD with relation to adiposity and insulin resistance are reviewed, and up-to-date diagnostic and therapeutic tools are also discussed.

Please view the full content in the pdf above.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.